View in EDS

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.

Saved in:
Bibliographic Details
Title: Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.
Authors: Groger M; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tona Lutete G; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mombo-Ngoma G; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Ntamabyaliro NY; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Kahunu Mesia G; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Muena Mujobu TB; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Dimessa Mbadinga LB; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Zoleko Manego R; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Egger-Adam D; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany., Borghini-Fuhrer I; Medicines for Malaria Venture, Geneva, Switzerland., Shin J; Shin-Poong Pharmaceutical, Seoul, Korea., Miller R; Medicines for Malaria Venture, Geneva, Switzerland., Arbe-Barnes S; Artemida Pharma, Stevenage, UK., Duparc S; Medicines for Malaria Venture, Geneva, Switzerland., Ramharter M; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: ramharter@bnitm.de.
Source: The Lancet. Microbe [Lancet Microbe] 2022 Aug; Vol. 3 (8), pp. e598-e605. Date of Electronic Publication: 2022 May 30.
Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35654079
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Groger+M%22">Groger M</searchLink>; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Tona+Lutete+G%22">Tona Lutete G</searchLink>; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Mombo-Ngoma+G%22">Mombo-Ngoma G</searchLink>; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.<br /><searchLink fieldCode="AU" term="%22Ntamabyaliro+NY%22">Ntamabyaliro NY</searchLink>; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Kahunu+Mesia+G%22">Kahunu Mesia G</searchLink>; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Muena+Mujobu+TB%22">Muena Mujobu TB</searchLink>; Unité de Pharmacologie Clinique et Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Dimessa+Mbadinga+LB%22">Dimessa Mbadinga LB</searchLink>; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.<br /><searchLink fieldCode="AU" term="%22Zoleko+Manego+R%22">Zoleko Manego R</searchLink>; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.<br /><searchLink fieldCode="AU" term="%22Egger-Adam+D%22">Egger-Adam D</searchLink>; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany.<br /><searchLink fieldCode="AU" term="%22Borghini-Fuhrer+I%22">Borghini-Fuhrer I</searchLink>; Medicines for Malaria Venture, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; Shin-Poong Pharmaceutical, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Miller+R%22">Miller R</searchLink>; Medicines for Malaria Venture, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Arbe-Barnes+S%22">Arbe-Barnes S</searchLink>; Artemida Pharma, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Duparc+S%22">Duparc S</searchLink>; Medicines for Malaria Venture, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ramharter+M%22">Ramharter M</searchLink>; Institut für Tropenmedizin, University of Tubingen, Tubingen, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: ramharter@bnitm.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2022 Aug; Vol. 3 (8), pp. e598-e605. <i>Date of Electronic Publication: </i>2022 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35654079
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2666-5247(22)00092-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e598
    Titles:
      – TitleFull: Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Groger M
      – PersonEntity:
          Name:
            NameFull: Tona Lutete G
      – PersonEntity:
          Name:
            NameFull: Mombo-Ngoma G
      – PersonEntity:
          Name:
            NameFull: Ntamabyaliro NY
      – PersonEntity:
          Name:
            NameFull: Kahunu Mesia G
      – PersonEntity:
          Name:
            NameFull: Muena Mujobu TB
      – PersonEntity:
          Name:
            NameFull: Dimessa Mbadinga LB
      – PersonEntity:
          Name:
            NameFull: Zoleko Manego R
      – PersonEntity:
          Name:
            NameFull: Egger-Adam D
      – PersonEntity:
          Name:
            NameFull: Borghini-Fuhrer I
      – PersonEntity:
          Name:
            NameFull: Shin J
      – PersonEntity:
          Name:
            NameFull: Miller R
      – PersonEntity:
          Name:
            NameFull: Arbe-Barnes S
      – PersonEntity:
          Name:
            NameFull: Duparc S
      – PersonEntity:
          Name:
            NameFull: Ramharter M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2666-5247
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The Lancet. Microbe
              Type: main
ResultId 1